-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. ulster nightclub removes offensive billboard of female golfer
.
. 18 hours ago .
aubrey: by comparison, fresh produce continues to lose nutrients due to handling and oxidation. .